| Product Code: ETC9936887 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 | |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 United Kingdom (UK) Activated Clotting Time Testing Market Overview |
3.1 United Kingdom (UK) Country Macro Economic Indicators |
3.2 United Kingdom (UK) Activated Clotting Time Testing Market Revenues & Volume, 2021 & 2031F |
3.3 United Kingdom (UK) Activated Clotting Time Testing Market - Industry Life Cycle |
3.4 United Kingdom (UK) Activated Clotting Time Testing Market - Porter's Five Forces |
3.5 United Kingdom (UK) Activated Clotting Time Testing Market Revenues & Volume Share, By Product Type, 2021 & 2031F |
3.6 United Kingdom (UK) Activated Clotting Time Testing Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.7 United Kingdom (UK) Activated Clotting Time Testing Market Revenues & Volume Share, By Technology, 2021 & 2031F |
3.8 United Kingdom (UK) Activated Clotting Time Testing Market Revenues & Volume Share, By End- User, 2021 & 2031F |
3.9 United Kingdom (UK) Activated Clotting Time Testing Market Revenues & Volume Share, By Test, 2021 & 2031F |
4 United Kingdom (UK) Activated Clotting Time Testing Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of cardiovascular diseases in the UK |
4.2.2 Growing demand for point-of-care testing for clotting disorders |
4.2.3 Technological advancements in activated clotting time testing equipment |
4.2.4 Rising awareness about the importance of timely clotting time monitoring |
4.2.5 Government initiatives to improve healthcare infrastructure |
4.3 Market Restraints |
4.3.1 High cost associated with activated clotting time testing equipment |
4.3.2 Limited reimbursement policies for activated clotting time testing |
4.3.3 Lack of skilled healthcare professionals for conducting and interpreting ACT tests |
4.3.4 Stringent regulatory guidelines for ACT testing equipment |
4.3.5 Competition from alternative clotting time testing methods |
5 United Kingdom (UK) Activated Clotting Time Testing Market Trends |
6 United Kingdom (UK) Activated Clotting Time Testing Market, By Types |
6.1 United Kingdom (UK) Activated Clotting Time Testing Market, By Product Type |
6.1.1 Overview and Analysis |
6.1.2 United Kingdom (UK) Activated Clotting Time Testing Market Revenues & Volume, By Product Type, 2021- 2031F |
6.1.3 United Kingdom (UK) Activated Clotting Time Testing Market Revenues & Volume, By Point of Care, 2021- 2031F |
6.1.4 United Kingdom (UK) Activated Clotting Time Testing Market Revenues & Volume, By Clinical Laboratory Analyzer, 2021- 2031F |
6.2 United Kingdom (UK) Activated Clotting Time Testing Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 United Kingdom (UK) Activated Clotting Time Testing Market Revenues & Volume, By Cardiovascular, 2021- 2031F |
6.2.3 United Kingdom (UK) Activated Clotting Time Testing Market Revenues & Volume, By Vascular Surgery, 2021- 2031F |
6.2.4 United Kingdom (UK) Activated Clotting Time Testing Market Revenues & Volume, By ECMO, 2021- 2031F |
6.2.5 United Kingdom (UK) Activated Clotting Time Testing Market Revenues & Volume, By Cardiac Catheterization Laboratories, 2021- 2031F |
6.2.6 United Kingdom (UK) Activated Clotting Time Testing Market Revenues & Volume, By Critical Care Units, 2021- 2031F |
6.2.7 United Kingdom (UK) Activated Clotting Time Testing Market Revenues & Volume, By Hemodialysis Units, 2021- 2031F |
6.3 United Kingdom (UK) Activated Clotting Time Testing Market, By Technology |
6.3.1 Overview and Analysis |
6.3.2 United Kingdom (UK) Activated Clotting Time Testing Market Revenues & Volume, By Fluorescent Based Detection, 2021- 2031F |
6.3.3 United Kingdom (UK) Activated Clotting Time Testing Market Revenues & Volume, By Optical Detection, 2021- 2031F |
6.3.4 United Kingdom (UK) Activated Clotting Time Testing Market Revenues & Volume, By Laser Based Detection, 2021- 2031F |
6.3.5 United Kingdom (UK) Activated Clotting Time Testing Market Revenues & Volume, By Mechanical Detection, 2021- 2031F |
6.4 United Kingdom (UK) Activated Clotting Time Testing Market, By End- User |
6.4.1 Overview and Analysis |
6.4.2 United Kingdom (UK) Activated Clotting Time Testing Market Revenues & Volume, By Academic & Research Institutes, 2021- 2031F |
6.4.3 United Kingdom (UK) Activated Clotting Time Testing Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.4.4 United Kingdom (UK) Activated Clotting Time Testing Market Revenues & Volume, By Clinical Laboratories, 2021- 2031F |
6.4.5 United Kingdom (UK) Activated Clotting Time Testing Market Revenues & Volume, By Ambulatory Surgical Centers, 2021- 2031F |
6.5 United Kingdom (UK) Activated Clotting Time Testing Market, By Test |
6.5.1 Overview and Analysis |
6.5.2 United Kingdom (UK) Activated Clotting Time Testing Market Revenues & Volume, By Platelet Function, 2021- 2031F |
6.5.3 United Kingdom (UK) Activated Clotting Time Testing Market Revenues & Volume, By Prothrombin Time, 2021- 2031F |
6.5.4 United Kingdom (UK) Activated Clotting Time Testing Market Revenues & Volume, By Fibrinogen, 2021- 2031F |
6.5.5 United Kingdom (UK) Activated Clotting Time Testing Market Revenues & Volume, By Activated Partial Thromboplastin Time, 2021- 2031F |
6.5.6 United Kingdom (UK) Activated Clotting Time Testing Market Revenues & Volume, By Activated Clotting Time, 2021- 2031F |
6.5.7 United Kingdom (UK) Activated Clotting Time Testing Market Revenues & Volume, By D Dimer, 2021- 2031F |
7 United Kingdom (UK) Activated Clotting Time Testing Market Import-Export Trade Statistics |
7.1 United Kingdom (UK) Activated Clotting Time Testing Market Export to Major Countries |
7.2 United Kingdom (UK) Activated Clotting Time Testing Market Imports from Major Countries |
8 United Kingdom (UK) Activated Clotting Time Testing Market Key Performance Indicators |
8.1 Adoption rate of activated clotting time testing in healthcare facilities |
8.2 Average turnaround time for conducting ACT tests |
8.3 Rate of accuracy in ACT test results |
8.4 Frequency of calibration and maintenance of ACT testing equipment |
8.5 Number of research studies or publications validating the efficacy of ACT testing |
9 United Kingdom (UK) Activated Clotting Time Testing Market - Opportunity Assessment |
9.1 United Kingdom (UK) Activated Clotting Time Testing Market Opportunity Assessment, By Product Type, 2021 & 2031F |
9.2 United Kingdom (UK) Activated Clotting Time Testing Market Opportunity Assessment, By Application, 2021 & 2031F |
9.3 United Kingdom (UK) Activated Clotting Time Testing Market Opportunity Assessment, By Technology, 2021 & 2031F |
9.4 United Kingdom (UK) Activated Clotting Time Testing Market Opportunity Assessment, By End- User, 2021 & 2031F |
9.5 United Kingdom (UK) Activated Clotting Time Testing Market Opportunity Assessment, By Test, 2021 & 2031F |
10 United Kingdom (UK) Activated Clotting Time Testing Market - Competitive Landscape |
10.1 United Kingdom (UK) Activated Clotting Time Testing Market Revenue Share, By Companies, 2024 |
10.2 United Kingdom (UK) Activated Clotting Time Testing Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |